规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Sotuletinib (BLZ945) hydrochloride acts as a potent, selective, and brain-penetrating inhibitor of CSF-1R (c-Fms), demonstrating an IC50 of 1 nM. It exhibits over 1,000-fold selectivity compared to its nearest receptor tyrosine kinase relatives[1]. |
Animal study | Mice receiving Sotuletinib hydrochloride or a vehicle are monitored for symptom-free survival, with the vehicle group showing a median survival of 5-7 weeks. Remarkably, Sotuletinib hydrochloride markedly extends long-term survival, with 64.3% of subjects alive at the 26-week trial conclusion, a duration chosen due to spontaneous tumor development in Ink4a/Arf / mice around ~30 weeks. Sotuletinib hydrochloride demonstrates a high tolerance in prolonged treatment without noticeable side effects, aligning with histopathological findings. Histological analysis shows all vehicle-treated mice developed high-grade, invasive gliomas, whereas Sotuletinib hydrochloride treatment results in significantly less malignant tumors, with 55.6% of asymptomatic mice showing no detectable lesions at the trial's end[1].Mice treated with Sotuletinib hydrochloride exhibit decreased CSF1R staining in cervical tumors and their surrounding stroma, demonstrating a notable reduction in CSF1R+ stromal macrophages compared to those treated with the vehicle (P<0.05)[2]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.30mL 0.46mL 0.23mL |
11.50mL 2.30mL 1.15mL |
22.99mL 4.60mL 2.30mL |
CAS号 | 2222138-31-8 |
分子式 | C20H23ClN4O3S |
分子量 | 434.94 |
SMILES Code | O=C(NC)C1=NC=CC(OC2=CC=C3N=C(N[C@H]4[C@H](O)CCCC4)SC3=C2)=C1.[H]Cl |
MDL No. | N/A |
别名 | BLZ945 hydrochloride |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Inert atmosphere, room temperature |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|